Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-583-7 | CAS number: 55302-96-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral (gavage): LD0: > 2,000 mg/kg for female rat (limit test; OECD Guideline 420, GLP, Klimisch 1)
Dermal: LD50: > 2,000 mg/kg for male and female rat (limit test; OECD Guideline 402, GLP, Klimisch 1)
Inhalation: no study available
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Acute oral toxicity:
The one key acute oral toxicity study (OECD guideline 420 -limit test, GLP, Klimisch 1), in which Sprague-Dawley female rats were given a single gavage dose (2000 mg/kg bw) of 2-Methyl-5-hydroxyethylaminophenol, gave a maximum non-lethal dose higher than 2000 mg/kg bw. Hypoactivity or sedation, piloerection and dyspnea were observed in all animals on day 1 within the 2 hours following the treatment. No clinical signs were observed thereafter on day 1 but from day 2 up to day 5 and then on days 14 and 15, noisy breathing was observed in 1/4 animals. This clinical sign was associated with piloerection and swollen abdomen on days 14 and 15. A body weight loss was seen in 1/4 females between days 1 and 15. The overall body weight gain of the other animals was similar to that of testing laboratory historical control animals. Macroscopic examination of the main organs of the animals revealed no apparent abnormalities.
Acute dermal toxicity:
The one key acute dermal toxicity study (OECD guideline 402 -limit test, GLP, Klimisch 1) in which male and female Sprague-Dawley rats were administered a single dose (2000 mg/kg bw) of 2-Methyl-5-hydroxyethylamino-phenol for 24 hours under semiocclusive coverage, gave an LD50 value > 2000 mg/kg bw. No deaths and no clinical signs were observed during the study. An orange coloration of the skin was observed in all animals from day 2 until day 6 (1/5 males), day 10 (another male) or day 15 (3/5 males and 5/5 females). An erythema was noted in 2/10 animals on day 2; it persisted in one of them until day 6. A dryness of the skin was noted in 1/10 animals from day 3 until day 6. Crusts were observed in 3/10 animals from day 7 until day 10 (2/3 animals) or day 15 (1/3 animals).
When compared to the testing laboratory historical control animals, a slightly lower body weight gainnwas noted in 1/5 males and 1/5 females between day 1 and day 8; it returned to normal thereafter. The
body weight gain of the other animals was not affected by treatment with the test item. No apparent abnormalities were observed at necropsy in any animal.
Acute inhalation toxicity:
According to column 2 in the table given in REACH Annex VIII, acute inhalation toxicity, "Testing by the inhalation route is appropriate if exposure of humans via inhalation is likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size." According to Chapter R.7a: Endpoint specific guidance (Version 5.0 - December 2016) (pages 356 -357), a waiving should be considered for 2-Methyl-5-hydroxyethylaminophenol as the inhalation route is not relevant for this substance.
Justification for classification or non-classification
There are no existing or proposed classifications for the acute toxicity of 2-Methyl-5-hydroxyethylaminophenol.
Acute oral toxicity:
Based on the results of the one key study (OECD guideline 420 -limit test, GLP, Klimisch 1) giving an LD0 > 2000 mg/kg bw in the rat, 2-Methyl-5-hydroxyethylaminophenol is not classified as hazardous for acute oral toxicity according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging (CLP) criteria.
Acute dermal toxicity:
Based on the results of the one key study (OECD guideline 402 -limit test, GLP, Klimisch 1) giving an LD50 > 2000 mg/kg bw in the rat without mortality, clinical signs or macroscopic findings, 2-Methyl-5-hydroxyethylaminophenol is not classified as hazardous for acute dermal toxicity according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging (CLP) and the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.